Danaher Corporation (DHR) Stake Raised by Pictet Asset Management Ltd.
Pictet Asset Management Ltd. grew its position in Danaher Corporation (NYSE:DHR) by 19.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,194,728 shares of the conglomerate’s stock after acquiring an additional 515,725 shares during the quarter. Danaher Corporation comprises about 0.8% of Pictet Asset Management Ltd.’s portfolio, making the stock its 13th largest position. Pictet Asset Management Ltd. owned 0.46% of Danaher Corporation worth $274,044,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. GQG Partners LLC purchased a new position in Danaher Corporation in the 2nd quarter worth about $101,000. Proficio Capital Partners LLC increased its stake in Danaher Corporation by 92.3% in the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after buying an additional 598 shares during the period. Monetary Management Group Inc. increased its stake in Danaher Corporation by 10.7% in the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after buying an additional 150 shares during the period. Acrospire Investment Management LLC increased its stake in Danaher Corporation by 185.5% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after buying an additional 1,100 shares during the period. Finally, ClariVest Asset Management LLC purchased a new position in Danaher Corporation in the 1st quarter worth about $157,000. 75.38% of the stock is currently owned by institutional investors and hedge funds.
DHR has been the topic of several recent analyst reports. J P Morgan Chase & Co reaffirmed an “overweight” rating and issued a $95.00 price target on shares of Danaher Corporation in a research note on Friday, September 8th. Wells Fargo & Company reiterated a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a report on Thursday, October 5th. Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the stock a “buy” rating in a report on Friday, July 21st. Finally, Morgan Stanley reiterated an “overweight” rating and set a $95.00 target price (up from $86.00) on shares of Danaher Corporation in a report on Friday, October 6th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $93.31.
In other Danaher Corporation news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of Danaher Corporation stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the sale, the chief executive officer now owns 271,737 shares of the company’s stock, valued at approximately $25,173,715.68. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider William King sold 43,688 shares of Danaher Corporation stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the sale, the insider now directly owns 45,748 shares in the company, valued at approximately $3,790,679.28. The disclosure for this sale can be found here. Insiders sold a total of 279,628 shares of company stock worth $25,304,394 in the last three months. 12.20% of the stock is owned by corporate insiders.
Danaher Corporation (NYSE DHR) opened at $93.33 on Tuesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The firm has a market cap of $64,162.62, a P/E ratio of 23.71, a PEG ratio of 2.19 and a beta of 1.02. Danaher Corporation has a 1-year low of $76.27 and a 1-year high of $93.38.
Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The business’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.87 EPS. sell-side analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend was Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is 16.52%.
COPYRIGHT VIOLATION WARNING: This story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.dailypolitical.com/2017/11/14/danaher-corporation-dhr-stake-raised-by-pictet-asset-management-ltd.html.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.